AIMS/HYPOTHESIS: Obesity causes an imbalance in fat mass distribution between visceral and subcutaneous adipose tissue (AT) depots. We tested the hypothesis that this relates to increased NEFA uptake between these depots in obese compared with healthy participants. Second, we hypothesised that a diet very low in energy (very low calorie diet [VLCD]) decreases fat mass in obese participants and that this is associated with the decline in NEFA uptake. METHODS: NEFA uptake in AT depots was measured with [(18)F]-fluoro-6-thia-heptadecanoic acid ((18)F-FTHA) and positron emission tomography (PET) in 18 obese participants with the metabolic syndrome before and after a 6 week VLCD. Whole body fat oxidation was measured using indirect calorimetry and [U-(13)C]palmitate. Sixteen non-obese participants were controls. RESULTS: Obese participants had >100% higher (p < 0.0001) NEFA uptake in the visceral and subcutaneous abdominal AT depots than controls. VLCD decreased AT mass in all regions (12% to 21%), but NEFA uptake was decreased significantly (18%; p < 0.006) only in the femoral AT. Whole body carbohydrate oxidation decreased, while fat oxidation increased. CONCLUSIONS/ INTERPRETATION: The data demonstrate that weight loss caused by VLCD does not affect abdominal fasting NEFA uptake rates. We found that visceral fat takes up more NEFAs than subcutaneous AT depots, even after weight loss.
AIMS/HYPOTHESIS: Obesity causes an imbalance in fat mass distribution between visceral and subcutaneous adipose tissue (AT) depots. We tested the hypothesis that this relates to increased NEFA uptake between these depots in obese compared with healthy participants. Second, we hypothesised that a diet very low in energy (very low calorie diet [VLCD]) decreases fat mass in obeseparticipants and that this is associated with the decline in NEFA uptake. METHODS:NEFA uptake in AT depots was measured with [(18)F]-fluoro-6-thia-heptadecanoic acid ((18)F-FTHA) and positron emission tomography (PET) in 18 obeseparticipants with the metabolic syndrome before and after a 6 week VLCD. Whole body fat oxidation was measured using indirect calorimetry and [U-(13)C]palmitate. Sixteen non-obeseparticipants were controls. RESULTS:Obeseparticipants had >100% higher (p < 0.0001) NEFA uptake in the visceral and subcutaneous abdominal AT depots than controls. VLCD decreased AT mass in all regions (12% to 21%), but NEFA uptake was decreased significantly (18%; p < 0.006) only in the femoral AT. Whole body carbohydrate oxidation decreased, while fat oxidation increased. CONCLUSIONS/ INTERPRETATION: The data demonstrate that weight loss caused by VLCD does not affect abdominal fasting NEFA uptake rates. We found that visceral fat takes up more NEFAs than subcutaneous AT depots, even after weight loss.
Authors: Sébastien M Labbé; Thomas Grenier-Larouche; Etienne Croteau; François Normand-Lauzière; Frédérique Frisch; René Ouellet; Brigitte Guérin; Eric E Turcotte; André C Carpentier Journal: Am J Physiol Endocrinol Metab Date: 2010-11-23 Impact factor: 4.310
Authors: Marco Bucci; Ronald Borra; Kjell Någren; Romina Maggio; Helena Tuunanen; Vesa Oikonen; Silvia Del Ry; Tapio Viljanen; Markku Taittonen; Sara Rigazio; Daniela Giannessi; Riitta Parkkola; Juhani Knuuti; Pirjo Nuutila; Patricia Iozzo Journal: Am J Physiol Endocrinol Metab Date: 2011-04-19 Impact factor: 4.310
Authors: Jarna C Hannukainen; Kari K Kalliokoski; Ronald J M Borra; Antti P M Viljanen; Tuula Janatuinen; Urho M Kujala; Jaakko Kaprio; Olli J Heinonen; Tapio Viljanen; Merja Haaparanta; Patricia Iozzo; Riitta Parkkola; Pirjo Nuutila Journal: Obesity (Silver Spring) Date: 2009-08-20 Impact factor: 5.002
Authors: John P Thyfault; Raymond M Kraus; Robert C Hickner; Amy W Howell; Robert R Wolfe; G Lynis Dohm Journal: Am J Physiol Endocrinol Metab Date: 2004-07-27 Impact factor: 4.310
Authors: Susanne B Votruba; Rebecca S Mattison; Daniel A Dumesic; Christina Koutsari; Michael D Jensen Journal: Diabetes Date: 2007-07-30 Impact factor: 9.461
Authors: Jason R Berggren; Kristen E Boyle; William H Chapman; Joseph A Houmard Journal: Am J Physiol Endocrinol Metab Date: 2008-02-05 Impact factor: 4.310
Authors: Robert M Badeau; Miikka-Juhani Honka; Marco Bucci; Patricia Iozzo; Johan G Eriksson; Pirjo Nuutila Journal: Nutrients Date: 2017-02-04 Impact factor: 5.717
Authors: P Petrus; D Edholm; F Rosqvist; I Dahlman; M Sundbom; P Arner; M Rydén; U Risérus Journal: Int J Obes (Lond) Date: 2017-05-03 Impact factor: 5.095
Authors: Andreas Paulus; Marco Maenen; Natascha Drude; Emmani B M Nascimento; Wouter D van Marken Lichtenbelt; Felix M Mottaghy; Matthias Bauwens Journal: PLoS One Date: 2017-08-17 Impact factor: 3.240
Authors: Andreas Paulus; Natascha Drude; Emmani B M Nascimento; Eva M Buhl; Jimmy F P Berbée; Patrick C N Rensen; Wouter D van Marken Lichtenbelt; Felix M Mottaghy; Matthias Bauwens Journal: Sci Rep Date: 2019-02-25 Impact factor: 4.379
Authors: Sanna Maria Honkala; Piryanka Motiani; Riikka Kivelä; Karthik Amudhala Hemanthakumar; Erik Tolvanen; Kumail Kumar Motiani; Jari-Joonas Eskelinen; Kirsi A Virtanen; Jukka Kemppainen; Marja Anneli Heiskanen; Eliisa Löyttyniemi; Pirjo Nuutila; Kari K Kalliokoski; Jarna Christina Hannukainen Journal: BMJ Open Diabetes Res Care Date: 2020-08